Clinical Trial: To Assess The Patient Preference for Goserelin Microsphere Versus Goserelin Implant in Patients With Prostate Cancer

U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06385847) titled 'To Assess The Patient Preference for Goserelin Microsphere Versus Goserelin Implant in Patients With Prostate Cancer' on April 24.

Brief Summary: The GOMIMP will be a Prospective, Randomized, Cross-over Trial to Explore the Patient Preference for Goserelin Microsphere (Zoladex(R)) Versus Goserelin Implant (LY01005) in Patients of Prostate Cancer

Study Type: Interventional

Condition: Prostate Cancer

Intervention: * Drug: Zoladex

Patients received 3.6 mg subcutaneous Zoladex

* Drug: LY01005

Patients received 3.6 mg intramuscular LY01005

Recruitment Status: Recruiting

Published by HT Digital Content Services with permission fr...